Esin Olcucuoğlu

Dr. Esin Olcucuoğlu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Current Medical Imaging
Verified
Journal Article
Closed access
PDF file
SSSamet Senel
Samet Senel
STSedat Tastemur
Sedat Tastemur
EOEsin Olcucuoğlu
Esin Olcucuoğlu
EUEmre Uzun
Emre Uzun
Objective: To examine the relation between perirenal fat volume, which is one of the visceral fat measurements, and kidney stones. Method: 169 patients admitted to our clinic between January 2018 and May 2021 were included in the study. The patients were divided into 2 groups as Control Group and Unilateral Kidney Stone Group (88 patients with unilateral kidney stones). Contrast-enhanced abdominal computed tomography scans were used to measure perirenal fat volume and the results were transferred to workstations. The total perirenal fat volumes in the bilateral kidneys of patients were compared between the two groups. The perirenal fat volume in stone-bearing and non-stone bearing kidneys of patients were also compared. Results: The total perirenal fat volume was higher in the Unilateral Kidney Stone Group than in the other groups and the perirenal fat volume of the patients in this group was higher in the stone bearing kidney (295.6±164.4cm3) than in the non-stone bearing kidney (273.1±179.6cm3). In the ROC analysis, it was concluded that total perirenal fat volume>387cm3 increased the risk of kidney stones. Presence of hypertension, presence of hyperlipidemia and total perirenal fat volume>387cm3 were found to be independent risk factors for the presence of kidney stones. Conclusion: Perirenal fat volume is higher in stone bearing kidneys compared to non-stone bearing kidneys. Therefore, stone formation in a kidney is directly related to the perirenal fat volume of that kidney. Also, total perirenal fat volume>387cm3 increases the risk of kidney stones independently of body mass index, and predicts it better.

16 August 2022 in Andrologia
Verified
Journal Article
Closed access
MBMuhammed Said Beşler
Muhammed Said Beşler
MGMuhammet Batuhan Gökhan
Muhammet Batuhan Gökhan
EOEsin Olcucuoğlu
Esin Olcucuoğlu
FÖFatma Ayça Edis Özdemir
Fatma Ayça Edis Özdemir

1 January 2018 in Urology Research and Practice
Verified
Journal Article
Closed access
MÖMahmut Taha Ölçücü
Mahmut Taha Ölçücü
NÖNazlı Ölçücü
Nazlı Ölçücü
EÖErkan ölçücüoğlu
Erkan ölçücüoğlu
EOEsin Olcucuoğlu
Esin Olcucuoğlu
YÖYaşar Özgök
Yaşar Özgök
Tubular ectasia of rete testis (TERT) is a rarely seen benign condition of testis which can cause chronic orchalgia. TERT appears as an anechoic lesion in ultrasonography. However magnetic resonance imaging is a more sophisticated diagnostic tool. TERT is commonly associated with epididymal cysts. Generally a conservative treatment approach is preferred. In some cases surgery is required. In our case, 54-year-old male patient had bilateral TERT associated with bilateral multiple epididymal cysts. He had chronic testicular pain which did not respond to first- line conservative treatments. After use of duloxetine (60 mg PO) plus gabapentine (400 mg PO) combination as a second-line conservative treatment, the patient dramatically responded to this treatment.The patients who have chronic testicular pain caused by bilateral TERT and multiple epididymal cysts may be treated with combination of duloxetine (60 mg PO) plus gabapentine (400 mg PO) combination. Cite this article as: Ölçücü MT, Ölçücü N, Ölçücüoğlu E, Ata Ölçücüoğlu E, Özgök Y. Response to duloxetine and gabapentin combination of a patient who has chronical orchialgia with bilateral tubular ectasia of rete testis and multiple epididymal cysts. Turk J Urol 2018; 44(3): 274-7.

24 March 2026 in Abdominal Radiology
Verified
Journal Article
Closed access
EOEsin Olcucuoğlu
Esin Olcucuoğlu
ITİlYas Tenlik
İlYas Tenlik
MGMuhammet Batuhan Gökhan
Muhammet Batuhan Gökhan
HTHalil Tekdemir
Halil Tekdemir
YGYasin Celal Güneş
Yasin Celal Güneş
ÖÖÖmer Öztürk
Ömer Öztürk

5 September 2025 in Medicina
Verified
Journal Article
Open access
PDF file
EOEsin Olcucuoğlu
Esin Olcucuoğlu
UÖUtku Eren Özkaya
Utku Eren Özkaya
MPMuhammed Emin Polat
Muhammed Emin Polat
MYMehmet Yilmaz
Mehmet Yilmaz
STSedat Tastemur
Sedat Tastemur
EÖErkan ölçücüoğlu
Erkan ölçücüoğlu
Background and Objectives: The impact of sarcopenia and myosteatosis on renal transplantation (RT) outcomes has yet to be explained, certainly due to differences in assessment methods. The role of visceral adiposity is also not clearly defined. This retrospective study aimed to evaluate pretransplant body composition—including sarcopenia, myosteatosis, and visceral adiposity ratio (VSR)—using computed tomography (CT) and analyze their relationship with short- and long-term graft outcomes. Materials and Methods: A total of 94 patients who underwent RT between 2019 and 2023 and had pretransplant non-contrast abdominal CT scans were included. Skeletal muscle area (SMA) was assessed at the L3 vertebral level, including multiple muscle groups. Sarcopenia was defined by a low skeletal muscle index (SMI), while myosteatosis was defined by high intramuscular adipose tissue content (IMAC). Visceral adiposity was evaluated by the visceral-to-subcutaneous adipose tissue ratio (VSR). These parameters were compared with post-transplant outcomes. Results: The mean age was 42.69 ± 12.47 years, with 54.3% male patients. High IMAC was significantly associated with early graft failure (p = 0.026), delayed graft function (p = 0.005), death-censored graft failure (p = 0.036), and overall graft failure (p = 0.047). One-year mortality was also higher in the high IMAC group (14.8% vs. 0.0%, p = 0.012). SMI and VSR were not significantly associated with outcomes. Myosteatosis emerged as a significant risk factor in univariate analysis but was not independently predictive in multivariate analysis. Among the established risk factors identified in the study, recipient age was found to be a significant predictor for overall graft failure, donation type (cadaveric vs. living) for death-censored graft failure, and cold ischemia time for delayed graft function (OR: 1.068, 95% CI: 1.001–1.141, p = 0.049; OR: 147.7, 95% CI: 2.1—10,427.0, p = 0.021; OR: 1.003, 95% CI: 1.001–1.006, p = 0.023). Conclusions: Myosteatosis correlates with worse graft outcomes and higher mortality, but its independent prognostic value requires further investigation.

28 March 2024 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
EOEsin Olcucuoğlu
Esin Olcucuoğlu
MBMuhammed Said Beşler
Muhammed Said Beşler
MGMuhammet Batuhan Gökhan
Muhammet Batuhan Gökhan
DADerya Arı
Derya Arı
ÖÖÖMER ÖZTÜRK
ÖMER ÖZTÜRK
SÖSarper Ökten
Sarper Ökten
Amaç:Çalışmamızda Manyetik Rezonans Kolanjiopankreatografi (MRKP) ile Ana Safra Kanalında (ASK) dilatasyon izlenen, ama nedeni saptanamayan hastaların laboratuvar, görüntüleme ve histolojik verileri retrospektif olarak incelendi, tanısal algoritma oluşturmak için yol gösterici ipuçları ve bilgiler elde edilmesi amaçlandı. Gereç ve Yöntemler:ASK dilatasyonu nedeniyle MRKP yapılan ancak etiyolojisi kesin olarak belirlenemeyen 137 hastanın demografik verileri, klinik bulguları, laboratuvar sonuçları, MRKP, Endoultrasonografi (EUS) ve Endoskopik retrograd kolanjiopankreatografi (ERKP) bulguları, sitopatolojik sonuçlar ve takip verileri toplandı. MRKP'de aksiyel T2 ağırlıklı görüntülerde tek bir radyolog tarafından ortak hepatik kanaldaki en geniş seviyede ve koledok proksimalinde ölçümler yapılarak EUS ile karşılaştırıldı. Bulgular: Çalışma popülasyonunun yaş ortalaması 62.1±14.1 yıldı.Hastaların %28,5’i kadındı.MRKP'de ASK'nin ortalama çapı 11,8±3,1 mm iken, EUS'de ortalama çap 10,5±4,0 mm idi ve istatistiksel olarak anlamlı farklık vardı (p